ticagrelor
ticagrelor: sourced relationships with 2 companies · 3 clinical trials tracked · 2 FDA decisions.
ticagrelor evidence translation
What we can confirm
2 FDA records · 3 tracked trials
What it means
What to watch
Prepared research question
What is verified about ticagrelor, and what remains unknown?
Traceable citations · Unknowns marked
See linked entities and source evidence4 indications · 0 study sponsors
Related indications
Study sponsors
No additional listed-company sponsor is linked.
Dated Pipeline Records (2)
| Company | Dated record stage |
|---|---|
| ASTRAZENECA PLC (AZN) Reported 2011-07-20 · Current development: unknownSource Untreated Follicular Lymphoma | Approved |
| DR REDDYS LABORATORIES LTD (RDY) Reported 2024-10-29 · Current development: unknownSource | Approved |
Clinical Trial Registry Records (3)
Dual Antithrombotic Therapy With Dabigatran and Ticagrelor in Patients With Acute Coronary Syndrome and Non-valvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention (ADONIS-PCI)
Primary endpoint: Primary safety endpoint - first major or clinically relevant non-major bleeding event, as defined by the ISTH
The Value of Screening for "High on Treatment Platelet Reactivity" in Patients Undergoing Lower Extremity Arterial Endovascular Interventions
Primary endpoint: Proportion of Participants With Primary Patency
Single-center, Double-blind (ACT-246475), Open-label (Clopidogrel, Prasugrel, and Ticagrelor), Placebo-controlled, Randomized, Two-way Crossover Study to Investigate the Pharmacodynamics, Safety, and Tolerability of a Single Oral Dose of Clopidogrel or, Prasugrel, or Ticagrelor When Administered After a Single Subcutaneous Dose of the P2Y12 Antagonist ACT-246475 in Healthy Male and Female Subjects
Primary endpoint: Time-matched comparisons of IPA% (MPA) between treatments (i.e., Treatment A1 vs A2, Treatment B1 vs B2, and treatment C1 vs C2, treatments are defined below) following administration of ACT-246475 and its matching placebo.
FDA Decisions2 records
Frequently asked questions
Which companies have sourced relationships with ticagrelor?
ticagrelor has dated SEC/FDA relationship records for ASTRAZENECA PLC, DR REDDYS LABORATORIES LTD.
How many clinical trials involve ticagrelor?
BioSniper tracks 3 clinical trials involving ticagrelor.
What is ticagrelor's latest FDA decision?
The most recent tracked FDA decision for ticagrelor is Approval, dated October 29, 2024.